Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NANOSMART

Financiado

Cerrado

Smart nanoparticle system for lung cancer application

"As a result of the research undertook in the MYCAP ERC project, Dr Martín del Valle’s team have developed a new smart nanoparticle for delivering cisplatin, which is the current lung cancer standard of care (SoC). In order to acc... ver más

31/03/2014

USAL

159K€

Presupuesto del proyecto: 159K€

Líder del proyecto

UNIVERSIDAD DE SALAMANCA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 1151

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-03-31 No tenemos la información de la convocatoria

0% 90% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

USAL

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NANOTHER Integration of Novel Nanoparticle based Technology for Thera... 12M€ Cerrado

PID2020-118448RB-C22 DESARROLLO DE NANOSISTEMAS MULTIFUNCIONALES BASADOS EN METAL... 121K€ Cerrado

CellularNanoMachines Development of Stimuli Responsive Nanoparticle carrying T ly... 241K€ Cerrado

NANOTRAC Tracing the Intracellular Fate of Anticancer Nanomedicines 100K€ Cerrado

NANOFÁRMACOS PARA EL TRATAMIENTO DE CÁNCER DE... NANOFÁRMACOS PARA EL TRATAMIENTO DE CÁNCER DE MAMA BASADOS E... 1M€ Cerrado

PDC2021-121393-I00 NEW NANOPARTICULA INTELIGENTE PARA LIBERACION DE 5FU CANCEL... 146K€ Cerrado

Líder del proyecto

UNIVERSIDAD DE SALAMANCA No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 1151

Presupuesto del proyecto 159K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "As a result of the research undertook in the MYCAP ERC project, Dr Martín del Valle’s team have developed a new smart nanoparticle for delivering cisplatin, which is the current lung cancer standard of care (SoC). In order to accelerate its market entry, the present Proof of Concept (PoC) project, named NANOSPART, will conduct in vitro validation of cisplatin nanoparticles through cell lines culture assays, as well as the technological optimization of the drug delivering system and the upper spray-based technology arisen from MYCAP ERC funded. The work undertaken so far requires further investment in applied research, in order to turn the outputs shown above into a commercial proposition. The NANOSMART project will make an important contribution towards the future pre-clinical and clinical phases, and new key industrial applications. Dr. Martín del Valle´s team have developed a new drug delivery system (DDS) for lung cancer treatment based on polymer nanoparticles, as a result of MYCAP project. Dr Martín del Valle now aims to progress this idea to PoC through the NANOSMART project, which has mainly three goals: defining the right chemical properties of these nanoparticles; determining the optimal dose of cisplatin-conjugates in relation to toxicity and efficacy parameters; In terms of expected outcomes, the project will contribute to meet critical market needs in lung cancer treatment. Globally, lung cancer is one of the most common types of cancer, with an estimated 1.2 million new cases being diagnosed every year. Despite the emergence of new treatments, 85% of lung cancer patients don’t survive, which is mainly due to metastatic disease . Because of the overall poor prognosis, new treatment strategies for lung cancer patients are urgently needed. Dr. Eva Martín del Valle and her team from University of Salamanca, are willing to address this issue with a new approach that utilises novel nanopartictechnology to deliver the current SoC (cisplatin)."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores